ASRS
TVTX icon

Arizona State Retirement System’s Travere Therapeutics TVTX Stock Holding History

Arizona State Retirement System’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$694K Sell
23,347
-64
-0.3% -$1.91K ﹤0.01% 1303
2025
Q4 		$895K Sell
23,411
-1,553
-6% -$50.5K ﹤0.01% 1169
2025
Q3 		$597K Buy
24,964
+375
+2% +$7.05K ﹤0.01% 1403
2025
Q2 		$364K Buy
24,589
+1,225
+5% +$20.3K ﹤0.01% 1623
2025
Q1 		$419K Buy
23,364
+968
+4% +$19.6K ﹤0.01% 1511
2024
Q4 		$390K Buy
22,396
+2,666
+14% +$47.2K ﹤0.01% 1623
2024
Q3 		$276K Buy
19,730
+554
+3% +$5.77K ﹤0.01% 1814
2024
Q2 		$158K Sell
19,176
-1,476
-7% -$9.94K ﹤0.01% 1961
2024
Q1 		$159K Sell
20,652
-317
-2% -$2.67K ﹤0.01% 1991
2023
Q4 		$189K Buy
20,969
+1,851
+10% +$13.5K ﹤0.01% 1977
2023
Q3 		$171K Buy
19,118
+1,321
+7% +$18.6K ﹤0.01% 1953
2023
Q2 		$273K Buy
17,797
+1,992
+13% +$36.2K ﹤0.01% 1768
2023
Q1 		$355K Buy
15,805
+465
+3% +$9.88K ﹤0.01% 1596
2022
Q4 		$323K Buy
15,340
+669
+5% +$14.2K ﹤0.01% 1628
2022
Q3 		$361K Buy
14,671
+110
+0.8% +$2.84K ﹤0.01% 1519
2022
Q2 		$353K Sell
14,561
-334
-2% -$8.4K ﹤0.01% 1573
2022
Q1 		$384K Buy
14,895
+187
+1% +$4.96K ﹤0.01% 1643
2021
Q4 		$457K Sell
14,708
-113
-0.8% -$3.18K ﹤0.01% 1595
2021
Q3 		$359K Buy
14,821
+729
+5% +$13.4K ﹤0.01% 1722
2021
Q2 		$206K Sell
14,092
-999
-7% -$19.7K ﹤0.01% 2105
2021
Q1 		$377K Buy
15,091
+2,543
+20% +$70.3K ﹤0.01% 1690
2020
Q4 		$342K Sell
12,548
-187
-1% -$4.37K ﹤0.01% 1667
2020
Q3 		$235K Buy
+12,735
New +$248K ﹤0.01% 1710

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arizona State Retirement System's TVTX Position: Q1 2026 in Review

Arizona State Retirement System reduced its Travere Therapeutics (TVTX) stake by 0.27% in Q1 2026, selling an estimated $1.91K and leaving 23,347 shares worth $694K. The position accounts for ﹤0.01% of the portfolio, ranked #1303.

Arizona State Retirement System first reported a position in TVTX in Q3 2020 and has held it in 23 quarters since. The position peaked at $895K in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Arizona State Retirement System held 23,347 shares of Travere Therapeutics worth $694K as of Q1 2026.
  • Arizona State Retirement System sold 64 Travere Therapeutics shares in Q1 2026, an estimated $1.91K.
  • Travere Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1303 holding.
  • Arizona State Retirement System first reported a position in Travere Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Arizona State Retirement System's Travere Therapeutics position peaked at $895K in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.